Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation

NCT05655195 is registered in ClinicalTrials.gov with Massachusetts Institute of Technology as lead sponsor.

NCT NCT05655195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05655195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation
Lead sponsor
Massachusetts Institute of Technology
Phase
Not applicable
Overall status
Recruiting
Start date
December 14, 2022
Completion date
September 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, alzheimer disease, early onset, alzheimer disease, late onset, alzheimer's, alzheimer's disease, alzheimer's disease (incl subtypes)